“Design and Synthesis of Novel Triazole-Isofroxadin Molecules: Docking Studies Against Inflammatory and Tuberculosis Targets” (2025) Indian Journal of Chemistry (IJC), 64(3), pp. 285–290. doi:10.56042/ijc.v64i3.16320.